Inguinal Herniorrhaphy Clinical Trial
Official title:
A Randomized, Double-Blind, Placebo- and Active-Controlled, Dose Escalation and Optional Dose Expansion Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of CPL-01 in Postoperative Pain After Open Inguinal Herniorrhaphy
This is a Phase 2b, randomized, double blind, placebo and active controlled study with an Ascending Dose Stage and an optional Dose Expansion Stage in subjects undergoing open inguinal herniorrhaphy with mesh.
A Randomized, Double-Blind, Placebo- and Active-Controlled, Dose Escalation and Optional Dose Expansion Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of CPL-01 in the Management of Postoperative Pain After Open Inguinal Herniorrhaphy. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT00616577 -
Preemptive Analgesia in Children Using Caudal Epidural Ropivacaine
|
N/A | |
Terminated |
NCT03534505 -
Post-Operative Analgesic Effects of Local Wound Infiltration With Ketorolac After Inguinal Herniorrhaphy
|
N/A | |
Recruiting |
NCT06352606 -
Spinal and General Anesthesia in Neonates Undergoing Herniorrhaphy
|
N/A |